Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO
As part of the phase-II/III trial, the two-dose Covaxin was administered with 28 days apart.
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.